Srikanth Radhakrishnan - 02 Mar 2026 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
Chief Science &Techn. Officer
Signature
/s/ David Aaron Lehman, Attorney-in-Fact
Issuer symbol
LUNG
Transactions as of
02 Mar 2026
Net transactions value
-$14,991
Form type
4
Filing time
04 Mar 2026, 19:07:59 UTC
Previous filing
10 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Radhakrishnan Srikanth Chief Science &Techn. Officer C/O PULMONX CORPORATION, 700 CHESAPEAKE DRIVE, REDWOOD CITY /s/ David Aaron Lehman, Attorney-in-Fact 04 Mar 2026 0002098678

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale $1,081 -756 -0.42% $1.43 180,463 02 Mar 2026 Direct F1
transaction LUNG Common Stock Sale $4,387 -3,068 -1.7% $1.43 177,395 02 Mar 2026 Direct F2
transaction LUNG Common Stock Sale $3,519 -2,461 -1.4% $1.43 174,934 02 Mar 2026 Direct F3
transaction LUNG Common Stock Sale $6,003 -4,198 -2.4% $1.43 170,736 02 Mar 2026 Direct F4
transaction LUNG Common Stock Award +175,000 +102% $0.000000* 345,736 02 Mar 2026 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2022.
F2 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
F3 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.
F4 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025.
F5 Represents grant of RSUs payable solely in common stock of the Issuer that vest in equal quarterly installments over the four-year period from the grant date of March 2, 2026.